No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
No Data
No Data
No Data
Tissue Repair Ltd: Advancing Trials and Boosting Sales
TipRanksApr 30 05:19 ET
Tissue Repair Ltd Issues New Employee Options
TipRanksApr 4 05:07 ET
Tissue Repair Secures Third US Patent for Glucoprime Compound
Tissue Repair (ASX:TRP) secured a third US patent for its Glucoprime compound. Glucoprime and its variants form the underlying technology platform behind Tissue Repair's lead drug candidate TR987 for
MT NewswiresDec 18, 2023 22:51 ET
Tissue Repair's (ASX:TRP) Wound Healing Drug Cleared by FDA
The Market HeraldMay 28, 2023 19:26 ET
No Data
No Data